Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

BACKGROUND AND PURPOSE: High-risk prostate cancer patients are frequently treated with external-beam radiotherapy (EBRT). Of all patients receiving EBRT, 15–35% will experience biochemical recurrence (BCR) within five years. Magnetic resonance imaging (MRI) is commonly acquired as part of the diagno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Phys Imaging Radiat Oncol
Main Authors: Dinis Fernandes, Catarina, Dinh, Cuong V., Walraven, Iris, Heijmink, Stijn W., Smolic, Milena, van Griethuysen, Joost J.M., Simões, Rita, Losnegård, Are, van der Poel, Henk G., Pos, Floris J., van der Heide, Uulke A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807756/
https://ncbi.nlm.nih.gov/pubmed/33458399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phro.2018.06.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados